People with Down syndrome have a 9/10 chance of developing early-onset Alzheimer’s — a reality tied to genetics. This genetic condition also makes this…
Treatment with a powerful magnet is one of the newest experimental therapies being used to try to turn back the clock on Alzheimer’s disease….
Why are researchers still fumbling in the quest to cure what is arguably one of the most important diseases confronting humankind — Alzheimer’s disease?…
Editor’s note: This is a mouse study. Studies in mice rarely translate to humans. An inert and unreactive gas may not seem like an…
In the brains of people with Alzheimer’s diseases, problematic proteins called beta-amyloid build up and clump together in plaques, harming and eventually killing off…
Could a headset with flashing lights and sounds stimulate brain waves and treat Alzheimer’s? Cognito’s Phase 3 trial on such a device is trying…
With the 2024 FDA approval of Eli Lilly’s Kisunla for early-stage Alzheimer’s disease, there are now two fairly similar anti-amyloid on the market in…
Parasites take an enormous toll on human and veterinary health. But researchers may have found a way for patients with brain disorders and a…
On September 26th, Cassava Sciences’ founder and former CEO Remi Barbier, as well as former vice president Lindsay Burns agreed to pay the Securities…
While the world tracks the progress of disease-modifying Alzheimer’s anti-amyloids through the drug development and FDA approval pipeline, there are symptomatic treatments making their…
A new study from the UK suggests that the models used to screen for potential future cases of dementia are not reliable predictors of…
On August 22nd, the UK’s drug regulation agency — UK Medicines and Healthcare products Regulatory Agency — approved Eisai and Biogen’s anti-amyloid drug Leqembi…
Scientists in America have developed a nasal spray that can remove proteins in the brain associated with Alzheimer’s disease – at least, in mice….
What will Alzheimer’s treatment look like in five years? At 2024’s Alzheimer’s Association International Conference in Philadelphia, experts provided a sneak peek into the…
Update 17 July, 2024, 3:14 p.m. ET: Cassava Sciences CEO and SVP of neuroscience have resigned from the company following news of federal probes….